Consistently, after inhibiting LINC00958, BC cell viability was inhibited, and the iron content and ROS levels increased while GSH levels decreased, with elevated iron death-related protein ACSL4 expression and lower GPX4 expression in BC cells. The gene discussed is ACSL4; the disease is breast cancer.